University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, 53792-4108, United States
NCT Number: NCT04899245
The Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, is a worldwide pandemic that has resulted in large-scale quarantines in cities, states, and countries throughout the world. SARS-CoV-2 is a respiratory virus that is most commonly spread via contact with infective respiratory droplets and aerosols produced by coughing, sneezing, talking, and singing.
Children with medical complexity (CMC), i.e., children with multiple severe chronic conditions, high resource use, severe functional limitations, and substantial family-identified service needs, are a medically vulnerable population for the development of severe COVID-19. Deciding to send CMC to school poses a major dilemma to families wanting to minimize severe COVID-19 risk. School personnel also face risks when CMC attend school. Despite these challenges, achieving in-person school attendance is critical for CMC. Compared to non-CMC, academic and social development for most CMC hinges on being at school. Severe intellectual and developmental disability impairs one's ability to engage with online platforms. Health-promoting services delivered at school, e.g., physical, occupational, and speech therapy, are likely less effective when delivered virtually. Parents of CMC, already disproportionately unemployed due to their child's care needs, experience added employment strain when their child is out of school.
The study objective is to increase the safe return to school for CMC by 1) evaluating the feasibility of school-based COVID-19 testing strategies and 2) identifying parent and staff perceptions of testing and school attendance. A related study (ReSET Aim 1a, NCT04895085) will evaluate the same factors in home-based testing strategies in CMC exclusively.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Madison, Wisconsin, 53792-4108, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
BinaxNOW Rapid Antigen System (Abbott) is a point-of-care, lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs. Internal controls are built into the testing system and results are available in 15 minutes.
The use of the BinaxNOW system is authorized under the Food and Drug Administration's Emergency Use Authorization. The test is allowed for over-the-counter, non-prescription use with or without symptoms. The test may be used with children two years and older with the help of sample collection by an adult, and the test may be self-administered by anyone aged 15 years or more.
Time frame: Study duration (up to 21 months)
Feasibility of school based COVID-19 testing will be evaluated by protocol uptake. Data will be retrieved from the study log. Two data limitations to note:
Time frame: Every week up to 21 months
Time frame: Study duration (up to 21 months)
Data will be retrieved from study log.
Time frame: Study duration (up to 21 months)
Data will be retrieved from study log.
Time frame: Study duration (up to 21 months)
Data will be retrieved from study log. All children and staff (n = 71) were included in this outcome. However, participants were not required to and were sometimes unable to complete a confirmatory PCR test after a positive in-home rapid test. This explains the difference between the number of positive at-home COVID-19 tests and the number of PCR tests.
Some participants completed multiple confirmatory PCR tests over the study time frame. This explains why the PCR quantity is greater than the number of participants.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
The following question from the Participant's perceived susceptibility survey will be answered dichotomously and presented qualitatively:
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Following questions from the Participant's perceived susceptibility survey will be answered dichotomously (agree or disagree) and presented qualitatively.
Time frame: 15 month, 18 month, 21 month, 24 month
Parent survey perceived severity construct variables will include:
Time frame: 15 month, 18 month, 21 month, 24 month
Parent survey perceived severity construct variables will be:
Time frame: 15 month, 18 month, 21 month, 24 month
Parent survey perceived severity construct variables will be:
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Participants will answer the following survey question in quite a bit / a great deal vs not:
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, and impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely vs not.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Participants will answer the following survey question in Yes/No:
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Participant will be asked the attendance question in survey. It will be answered in Yes/No.
Time frame: Baseline, 3 month, 6 month, 9 month, 15 month, 18 month, 21 month, 24 month
Participant will be asked the attendance question in survey. It will be answered in Yes/No
University of Wisconsin, Madison
Other
ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - SARS-CoV-2 Testing in School With Children and Staff
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04895085
COVID-19, Children With Medical Complexity (CMC)
Madison, Wisconsin, United States
View Trial DetailsNCT04867395
Children With Medical Complexity (CMC)
New York, United States
View Trial DetailsNCT07652268
Children With Medical Complexity (CMC), Home Care Services
Hong Kong, China
View Trial DetailsNCT07167927
Children With Medical Complexity (CMC), Chronic Disease
Los Angeles, California, United States
View Trial Details